Disease: High-molecular-weight kininogen deficiency- congenital
- A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation
- A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate
- Acquired antibody to factor XI in a patient with congenital factor XI deficiency
- Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay
- Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
- Biological regulation by the kallikrein-kinin system: a study with a kininogen-deficient rat strain
- Blood coagulation disorders--special reference to thrombosis
- Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen
- Characterization of the heredity of kininogen deficiency in brown Norway Katholiek strain rats
- Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency
- Combined high molecular weight Kininogen and factor XI deficiency
- Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK)
- Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation
- Congenital prekallikrein deficiency
- Detection of surface-adsorbed (lipo)proteins by means of a two-step enzyme-immunoassay: a study on the Vroman effect
- Differentiation of kinin fractions in ureter urine and bladder urine of normal and kininogen-deficient rats
- Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas
- Fletcher factor, Fitzgerald factor
- Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat
- FXII
- Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma
- Intrinsic coagulation pathway in end-stage renal disease associated with spinal cord injury treated with hemodialysis
- Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity
- Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa
- New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion
- Participation of Hageman factor dependent pathways in human disease states
- Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay
- Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time
- Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII
- Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets
- Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma
- Role of high molecular weight (HMW)-kininogen in inflammatory exudation: evidence with the studies of the HMW-kininogen deficient rat
- Role of the plasma contact system in the pathogenesis of experimental anti-GBM glomerulonephritis
- The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI
- The significance of high molecular weight kininogen for contact activation of rat blood coagulation, in vitro